Market Cap 1.25B
Revenue (ttm) 310,000.00
Net Income (ttm) -149.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -48,151.61%
Debt to Equity Ratio 0.00
Volume 10,284,041
Avg Vol 5,985,524
Day's Range N/A - N/A
Shares Out 233.78M
Stochastic %K 10%
Beta 1.59
Analysts Strong Sell
Price Target $12.12

Company Profile

AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 332 282 0507
Address:
250 West 34th Street, New York, United States
McNick
McNick May. 13 at 10:21 AM
$ATAI was the partnership dialled down ?
0 · Reply
Lowkeyoptions
Lowkeyoptions May. 13 at 8:50 AM
$ATAI AtaiBeckley Joins $3.X Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst Inclusion in U.S. CRSP® benchmark indices triggers mandatory position-building by passive index funds tracking more than $3.X trillion in AUM, including the world’s largest mutual fund Expands market presence across the S&P Total Market Index, covering virtually all U.S.-listed equities, and the S&P Completion Index, which represents approximately 3,000 mid-, small-, and micro-cap companies not included in the S&P 500® Continues a series of index inclusions across the U.S. equity benchmark landscape, reflecting AtaiBeckley’s enhanced eligibility following its U.S. re-domiciliation and building on its addition to the Nasdaq Biotechnology Index in December 2025
0 · Reply
Hammy111
Hammy111 May. 13 at 3:10 AM
$ATAI with Christian out there shaking babies and kissing hands, for the next few weeks at Enhanced, possibly good exposure for ATAI. Guy is a pro at making connections and promoting ATAI. Let’s go.
0 · Reply
TheVisona
TheVisona May. 13 at 3:06 AM
0 · Reply
Framingtheworld
Framingtheworld May. 13 at 2:58 AM
$ATAI up on earnings of nothing is crazy
0 · Reply
Lowkeyoptions
Lowkeyoptions May. 12 at 11:47 PM
0 · Reply
Madharp270
Madharp270 May. 12 at 11:24 PM
0 · Reply
Madharp270
Madharp270 May. 12 at 11:14 PM
$ATAI is this about to rocket?
1 · Reply
UncleJudd
UncleJudd May. 12 at 10:36 PM
$ATAI Held the gain 🌈🍄
0 · Reply
matrixtrade123
matrixtrade123 May. 12 at 7:59 PM
$ATAI you know what you are holding and what I tell all my fellow Retail Investors is to +++++
0 · Reply
Latest News on ATAI
AtaiBeckley reports Q1 EPS (8c), consensus (11c)

2026-05-12T16:08:09.000Z - 19 hours ago

AtaiBeckley reports Q1 EPS (8c), consensus (11c)


AtaiBeckley Transcript: Needham Virtual Psychedelics Forum

Apr 27, 2026, 11:00 AM EDT - 15 days ago

AtaiBeckley Transcript: Needham Virtual Psychedelics Forum


AtaiBeckley price target raised to $15 from $14 at Canaccord

2026-04-20T13:22:59.000Z - 22 days ago

AtaiBeckley price target raised to $15 from $14 at Canaccord


Psychedelic stocks rally with Trump's support

Apr 20, 2026, 8:26 AM EDT - 22 days ago

Psychedelic stocks rally with Trump's support

CMPS DFTX GHRS


AtaiBeckley price target raised to $16 from $11 at Guggenheim

2026-04-17T12:28:41.000Z - 25 days ago

AtaiBeckley price target raised to $16 from $11 at Guggenheim


AtaiBeckley initiated with a Buy at Deutsche Bank

2026-03-27T08:55:15.000Z - 6 weeks ago

AtaiBeckley initiated with a Buy at Deutsche Bank


AtaiBeckley initiated with a Buy at Deutsche Bank

2026-03-26T23:25:13.000Z - 6 weeks ago

AtaiBeckley initiated with a Buy at Deutsche Bank


AtaiBeckley Transcript: Investor Day 2026

Mar 6, 2026, 9:00 AM EST - 2 months ago

AtaiBeckley Transcript: Investor Day 2026


AtaiBeckley Transcript: Study result

Feb 26, 2026, 8:00 AM EST - 2 months ago

AtaiBeckley Transcript: Study result


AtaiBeckley To Host Virtual Investor Day on March 6, 2026

Feb 20, 2026, 7:00 AM EST - 2 months ago

AtaiBeckley To Host Virtual Investor Day on March 6, 2026


AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

Dec 23, 2025, 7:00 AM EST - 5 months ago

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)


AtaiBeckley Transcript: Study Result

Nov 10, 2025, 8:00 AM EST - 6 months ago

AtaiBeckley Transcript: Study Result


AtaiBeckley Transcript: Study Update

Jul 1, 2025, 8:00 AM EDT - 11 months ago

AtaiBeckley Transcript: Study Update


AtaiBeckley Transcript: M&A Announcement

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Transcript: M&A Announcement


McNick
McNick May. 13 at 10:21 AM
$ATAI was the partnership dialled down ?
0 · Reply
Lowkeyoptions
Lowkeyoptions May. 13 at 8:50 AM
$ATAI AtaiBeckley Joins $3.X Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst Inclusion in U.S. CRSP® benchmark indices triggers mandatory position-building by passive index funds tracking more than $3.X trillion in AUM, including the world’s largest mutual fund Expands market presence across the S&P Total Market Index, covering virtually all U.S.-listed equities, and the S&P Completion Index, which represents approximately 3,000 mid-, small-, and micro-cap companies not included in the S&P 500® Continues a series of index inclusions across the U.S. equity benchmark landscape, reflecting AtaiBeckley’s enhanced eligibility following its U.S. re-domiciliation and building on its addition to the Nasdaq Biotechnology Index in December 2025
0 · Reply
Hammy111
Hammy111 May. 13 at 3:10 AM
$ATAI with Christian out there shaking babies and kissing hands, for the next few weeks at Enhanced, possibly good exposure for ATAI. Guy is a pro at making connections and promoting ATAI. Let’s go.
0 · Reply
TheVisona
TheVisona May. 13 at 3:06 AM
0 · Reply
Framingtheworld
Framingtheworld May. 13 at 2:58 AM
$ATAI up on earnings of nothing is crazy
0 · Reply
Lowkeyoptions
Lowkeyoptions May. 12 at 11:47 PM
0 · Reply
Madharp270
Madharp270 May. 12 at 11:24 PM
0 · Reply
Madharp270
Madharp270 May. 12 at 11:14 PM
$ATAI is this about to rocket?
1 · Reply
UncleJudd
UncleJudd May. 12 at 10:36 PM
$ATAI Held the gain 🌈🍄
0 · Reply
matrixtrade123
matrixtrade123 May. 12 at 7:59 PM
$ATAI you know what you are holding and what I tell all my fellow Retail Investors is to +++++
0 · Reply
BigCatNY
BigCatNY May. 12 at 7:43 PM
$ATAI I love the market. Out of despair it becomes hopeful. Ending green today. crazy after the shite start. Good luck everyone!
1 · Reply
BankOnTheFuture
BankOnTheFuture May. 12 at 7:36 PM
$CMPS $ATAI $DFTX $HELP Wonder if Makary being removed as FDA commissioner will have any effect on the psychedelic sector?
1 · Reply
OmFm
OmFm May. 12 at 7:22 PM
$ATAI this garbage never holds the gains
0 · Reply
Hanaleimike
Hanaleimike May. 12 at 7:11 PM
$ATAI I sold some Today…you’re welcome.
2 · Reply
TheVisona
TheVisona May. 12 at 6:26 PM
0 · Reply
matrixtrade123
matrixtrade123 May. 12 at 6:22 PM
$ATAI inclusion in the Russell Index is next Catalyst _ good Price Action today wouldn't you say !
0 · Reply
Lowkeyoptions
Lowkeyoptions May. 12 at 6:08 PM
$ATAI Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups Makary failed to win the staff's confidence after mass layoffs, leadership changes and a series of controversies in which the agency’s scientific principles appeared to be overridden by political interests, including those of RFK Jr. https://www.bostonherald.com/2026/05/12/fda-commissioner-resigning/
1 · Reply
mwhite9869
mwhite9869 May. 12 at 6:01 PM
$ATAI FDA Commissioner just resigned. 🤷🏼‍♂️
0 · Reply
banker4fun
banker4fun May. 12 at 5:47 PM
$ATAI back in the green were living the dream
0 · Reply
FLNY
FLNY May. 12 at 5:42 PM
0 · Reply
Lowkeyoptions
Lowkeyoptions May. 12 at 5:22 PM
$ATAI heavy cash on hand AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update AtaiBeckley Inc. Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression on track for Q2 2026 Cash and cash equivalents expected to fund operations through anticipated BPL-003 Phase 3 topline readouts, with runway into 2029 Cash position: Cash and cash equivalents as of March 31, 2026 expected to fund operations through anticipated BPL-003 Phase 3 topline readouts, with runway into 2029. Srinivas Rao, Co-Founder and Chief Executive Officer of AtaiBeckley, said: “Our $209.9 million in cash is expected to provide a runway through our anticipated Phase 3 topline readouts for BPL-003, as we advance toward the late-stage execution phase. Our near-term priority is initiating the Phase 3 ReConnection program for BPL-003 this quarter, while VLS-01 continues to progress toward anticipated Phase 2 topline results later this year.
0 · Reply
Cheeriosm32
Cheeriosm32 May. 12 at 4:37 PM
$ATAI CAN WE GET SOME LOVE.
1 · Reply